Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Recruiting

3 1 1 1
Investigated Drugs:
- Ro7589655
- Simoctocog Alfa
+3
Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

Recruiting

3 1 1 1
Investigated Drugs:
- Emicizumab
- Ro7589655
+5
A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

Recruiting

3 1 1
Investigated Drugs:
- Fidanacogene Elaparvovec
- Giroctocogene Fitelparvovec
A study of long-term safety and effectiveness of denecimig in people with haemophilia A with or without inhibitors

Recruiting

3 1 1
Investigated Diseases:
- Haemophilia A with anti factor VIII
- Factor VIII deficiency
+10
Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Recruiting

3 1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Efanesoctocog Alfa
+2
Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors

Recruiting

3 1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
+1
Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

Recruiting

3 1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Efanesoctocog Alfa
+4
Study on Personalized Dosing of Emicizumab for Patients with Congenital Hemophilia A

Recruiting

3 1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Emicizumab
Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

Recruiting

1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Ro7589655
Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors

Recruiting

3 1 1
Investigated Diseases:
- Factor IX deficiency
- Factor VIII deficiency
Investigated Drugs:
- Marstacimab
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes